Search research articles
Contact Us
Filters
Showing results (181-190 of 352) with videos related to
Page
of 36
Sort By:
Cancer Research
|
February 15, 1993
The role of cathepsin D in the invasiveness of human breast cancer cells
M D Johnson, J A Torri, M E Lippman, et al.
Human Reproduction (Oxford, England)
|
June 1, 1994
Progestins and antiprogestins in mammary tumour growth and metastasis
Y E Shi, Y E Liu, M E Lippman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1975
Competitive protein binding assay for methotrexate
C E Myers, M E Lippman, H M Elliot, et al.
West African Journal of Medicine
|
July 1, 1990
Progesterone receptors in advanced breast cancer
L C Chiedozi, K K Huff, M E Wesley, et al.
Clinical Endocrinology
|
August 1, 1983
Androgen receptor characteristics in skin fibroblasts from men with pubertal macromastia
C Eil, M E Lippman, E V De Moss, et al.
Cancer Research
|
January 15, 1994
MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands
S W McLeskey, I Y Ding, M E Lippman, et al.
Annals of Internal Medicine
|
February 1, 1983
Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer
D C Tormey, M E Lippman, B K Edwards, et al.
European Journal of Cancer
|
May 1, 1980
Combined effects of methotrexate and 5-fluoropyrimidine on human breast cancer cells in serum-free culture
R C Donehower, J C Allegra, M E Lippman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 21, 2001
Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays
J M Rae, M D Johnson, M E Lippman, et al.
Breast Cancer Research and Treatment
|
May 1, 1991
Insulin-like growth factors in human breast cancer
N Rosen, D Yee, M E Lippman, et al.
Page
of 36
Search research articles
Search
Showing results (181-190 of 352) with videos related to
Sort By:
Page
of 36
Cancer Research
|
February 15, 1993
The role of cathepsin D in the invasiveness of human breast cancer cells
M D Johnson, J A Torri, M E Lippman, et al.
Human Reproduction (Oxford, England)
|
June 1, 1994
Progestins and antiprogestins in mammary tumour growth and metastasis
Y E Shi, Y E Liu, M E Lippman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1975
Competitive protein binding assay for methotrexate
C E Myers, M E Lippman, H M Elliot, et al.
West African Journal of Medicine
|
July 1, 1990
Progesterone receptors in advanced breast cancer
L C Chiedozi, K K Huff, M E Wesley, et al.
Clinical Endocrinology
|
August 1, 1983
Androgen receptor characteristics in skin fibroblasts from men with pubertal macromastia
C Eil, M E Lippman, E V De Moss, et al.
Cancer Research
|
January 15, 1994
MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands
S W McLeskey, I Y Ding, M E Lippman, et al.
Annals of Internal Medicine
|
February 1, 1983
Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer
D C Tormey, M E Lippman, B K Edwards, et al.
European Journal of Cancer
|
May 1, 1980
Combined effects of methotrexate and 5-fluoropyrimidine on human breast cancer cells in serum-free culture
R C Donehower, J C Allegra, M E Lippman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 21, 2001
Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays
J M Rae, M D Johnson, M E Lippman, et al.
Breast Cancer Research and Treatment
|
May 1, 1991
Insulin-like growth factors in human breast cancer
N Rosen, D Yee, M E Lippman, et al.
Page
of 36